Respiratorius AB (publ)

Research Respiratorius AB (publ) (HF00) on Bullrun: market cap EUR 1.59M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHF00
• ExchangeF
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.59M
• Financial periodQ4 2025
• Net income-EUR 1.70M
• Free cash flow-EUR 529.00K

Valuation Snapshot

latest market cap is EUR 1.59M.

About Respiratorius AB (publ)

Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.

Frequently asked questions

What is Respiratorius AB (publ)'s market cap?

Respiratorius AB (publ)'s market capitalization is EUR 1.59M.

What does Respiratorius AB (publ) do?

Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma;